Gibson Christopher 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
Recursion (RXRX) Director Christopher Gibson Sells 40,000 Shares
What Happened
Christopher Gibson, a director of Recursion Pharmaceuticals (RXRX), converted Class B common shares into Class A shares and sold 40,000 shares in an open-market transaction on April 7, 2026. The shares were sold at $3.10 each for total proceeds of $124,000. The conversion is recorded at $0 per share (a conversion of convertible Class B into Class A).
Key Details
- Transaction date: 2026-04-07. Sale price: $3.10 per share; proceeds $124,000. Conversion price shown as $0 (conversion of Class B to Class A).
- Report filed: 2026-04-08 (timely filing).
- Transaction codes: C = conversion of a derivative/convertible security; S = sale (open market).
- Notable footnotes: F1 — Class B shares are convertible into Class A at holder’s option with no expiration; F2 — the sale was made pursuant to a Rule 10b5-1 trading plan adopted May 12, 2025. Other footnotes list holdings in family/LLC entities and option vesting schedules.
- Shares owned after the transaction are not specified in the provided filing excerpt.
Context
The filing shows a conversion of convertible (Class B) shares into Class A common stock and an immediate open‑market sale of those shares under a pre-established 10b5‑1 plan. Conversions at $0 reflect a change in share class rather than a paid option exercise. Sales under 10b5‑1 plans are typically prearranged and do not by themselves indicate the insider’s current view on the company.
Insider Transaction Report
- Conversion
Class A Common Stock
[F1][F2]2026-04-07+40,000→ 946,556 total - Sale
Class A Common Stock
[F2]2026-04-07$3.10/sh−40,000$124,000→ 906,556 total - Conversion
Class B Common Stock
[F1]2026-04-07−40,000→ 4,443,334 totalExercise: $0.00→ Class A Common Stock (40,000 underlying)
- 386,000(indirect: By LLC)
Class B Common Stock
[F1][F3]Exercise: $0.00→ Class A Common Stock (0 underlying) - 388,000(indirect: By LLC)
Class B Common Stock
[F1][F4]Exercise: $0.00→ Class A Common Stock (0 underlying) - 50,000(indirect: By Trust)
Class B Common Stock
[F1][F5]Exercise: $0.00→ Class A Common Stock (0 underlying) - 1,050,567
Stock Option (Right to Buy)
[F6]Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 666,898
Stock Option (Right to Buy)
[F7]Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 813,600
Stock Option (Right to Buy)
[F8]Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying) - 399,002
Stock Option (Right to Buy)
[F9]Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 5,436
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 282,500
Stock Option (Right to Buy)
[F10]Exercise: $2.48Exp: 2030-12-30→ Class A Common Stock (0 underlying)
Footnotes (10)
- [F1]Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- [F10]The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F2]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- [F3]The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- [F4]The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- [F5]The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F7]The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F8]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F9]The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.